Literature DB >> 28285148

Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis.

Enrico Capuzzi1, Francesco Bartoli2, Cristina Crocamo2, Massimo Clerici2, Giuseppe Carrà3.   

Abstract

Schizophrenia is likely to be associated with immunological abnormalities. However, antipsychotics may induce immunomodulatory effects, by influencing plasma cytokines. In order to distinguish these influences, we carried out a systematic review and meta-analysis exploring the acute effect of antipsychotics on candidate cytokines plasma levels (IL-1β, IL-2, IL-6, IL-17, IFN-γ, TNF-α) among drug-naïve subjects with first episode psychosis. We searched main Electronic Databases, identifying eight studies meeting our inclusion criteria. Plasma cytokines values were used to estimate standardized mean differences. Heterogeneity across studies was evaluated using the I2 index and controlled in relevant sensitivity analyses. IL-2 (p=0.023) and IL-6 (p=0.012) levels showed a significant decrease after four weeks of antipsychotic treatment. Relevant sensitivity analysis confirmed these findings. IL-1β had high between-study heterogeneity. However, leaving out one study, a significant decrease after treatment was found. IL-6 and IL-2, and possibly IL-1β, could be considered state markers, decreasing after antipsychotic treatment, whilst TNF-α, IL-17, and IFN-γ might be considered trait markers. Options for novel treatments in FEP, involving cytokine-modulating agents, should be further studied.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antipsychotics; Cytokines; First episode psychosis; Meta-analysis; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28285148     DOI: 10.1016/j.neubiorev.2017.03.003

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  22 in total

1.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

2.  Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia.

Authors:  Mohammad M Khan
Journal:  World J Psychiatry       Date:  2022-06-19

Review 3.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

Review 4.  Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.

Authors:  Yutaka Mizuki; Shinji Sakamoto; Yuko Okahisa; Yuji Yada; Nozomu Hashimoto; Manabu Takaki; Norihito Yamada
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

Review 5.  Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.

Authors:  Franziska A Radtke; Gareth Chapman; Jeremy Hall; Yasir A Syed
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

6.  The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice.

Authors:  Meghan May; Megan Beauchemin; Calvin Vary; Deborah Barlow; Karen L Houseknecht
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

7.  Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses.

Authors:  Ning Yuan; Yu Chen; Yan Xia; Jiacheng Dai; Chunyu Liu
Journal:  Transl Psychiatry       Date:  2019-09-18       Impact factor: 6.222

8.  Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis.

Authors:  Ryad Tamouza; Urs Meyer; Marianne Foiselle; Jean-Romain Richard; Ching-Lieng Lu; Wahid Boukouaci; Philippe Le Corvoisier; Caroline Barrau; Alexandre Lucas; Hervé Perron; Marion Leboyer
Journal:  Transl Psychiatry       Date:  2021-07-06       Impact factor: 6.222

9.  Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Miriam Ayora; Fabián Hernández-Álvarez; Alberto Rodríguez-Quiroga; Sandra Recio; Juan C Leza; Celso Arango
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 7.348

Review 10.  Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review.

Authors:  Livia J De Picker; Manuel Morrens; Steven A Chance; Delphine Boche
Journal:  Front Psychiatry       Date:  2017-11-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.